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Incidence and mortality rates of bladder cancer
vary about 10-fold worldwide. The highest
rates are found in North America and Europe,
and the rates are low in many parts of Asia
(Engel et al. 2002). In Taiwan, the incidence
and mortality rates of bladder cancer (per
100,000) in 2000 were 8.93 and 3.00 for males
and 3.87 and 1.36 for females, respectively
[Taiwan Department of Health (DOH) 2004].
Transitional cell carcinomas account for about
95% of bladder neoplasms. The remaining 5%
consist of squamous cell carcinomas, adenocar-
cinomas, and others (Engel et al. 2002).
Cigarette smoking and occupational exposures
are well-documented risk factors for bladder
cancer. Other known or suspected risk factors
for bladder cancer include race, sex, age,
lifestyle, chlorination by-products and arsenic
in drinking water, ionizing radiation, bladder
infection, high consumption of phenacetin-
containing analgesics, and hair dyes (Engel
et al. 2002). Several genetic susceptibility fac-
tors have been found to be related to bladder
cancer (Engel et al. 2002).
Bladder cancer is associated with a number
of occupational exposures. The ﬁrst such asso-
ciation was observed in 1895 (Rehn 1895),
and subsequent research among dyestuff work-
ers identified the aromatic amines benzidine
and 2-naphthylamine as bladder carcinogens
(Case et al. 1954). Several other aromatic
amines and related compounds have also been
identiﬁed as suspected human bladder carcino-
gens, including 1-naphthylamine, 4-amino-
biphenyl, 4-chloro-o-toluidine, o-toluidine,
and 4,4´-methylenedianiline [Engel et al.
2002; International Agency for Research on
Cancer (IARC) 1987]. Excess risk of bladder
cancer has also been observed among rubber
workers; painters; truck, bus, and taxi drivers;
aluminum workers; and leather workers
(Engel et al. 2002). It has been estimated that
these occupational exposures are responsible
for 18% of bladder cancer cases. As little as
2 years’ exposure may be sufﬁcient to increase
the risk, but the time between exposure and
subsequent cancer may be as long as 45 years
(Goroll et al. 2000).
4,4´-Methylenebis(2-chloroaniline)
(MBOCA) is used as a curing agent in indus-
tries that primarily produce castable poly-
urethane parts; thus, occupational exposure
may occur during the manufacturing processes
in these industries [Agency for Toxic
Substances and Disease Registry (ATSDR)
1994]. Workers may inhale MBOCA in small
particles in the air or absorb it through the skin
during contact with MBOCA dust or vapor.
Acute exposure to high levels of MBOCA may
cause eye and skin irritation in humans (Hosein
and Van Roosmalen 1978). Intermediate and
chronic exposure to MBOCA may lead to
tumors of the urinary bladder (ATSDR 1994;
Kommineni et al. 1979; Russﬁeld et al. 1975;
Stula et al. 1975, 1978). In a U.S. retrospective
bladder cancer incidence study, 385 of 532
workers ever exposed to MBOCA from 1968
to 1979 and 20 workers who were first
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A 52-year-old male chemical worker was admitted to the hospital with a history of paroxysmal
microscopic hematuria for about 2 years and nocturia with gross hematuria about ﬁve times per
night for 2 months. He was a nonsmoker and denied a history of any other bladder carcinogen
exposure except for occasional pesticide application during agricultural work. Intravenous urogram
imaging showed a mass occupying half of the bladder capacity. Cystoscopy revealed a mass over the
left dome of the bladder. Cystoscopic biopsy revealed a grade 3 invasive transitional cell carcinoma
with marked necrosis. From 1987 until hospital admission in 2001, the patient had worked in a
company that produced the 4,4´-methylenebis(2-chloroaniline) (MBOCA) curing agent. He did
not wear any personal protective equipment during work. Ambient air MBOCA levels in the puriﬁ-
cation process area (0.23–0.41 mg/m3) exceeded the U.S. Occupational Safety and Health
Administration’s permissible exposure level. Urinary MBOCA levels (267.9–15701.1 µg/g creati-
nine) far exceeded the California Occupational Safety and Health Administration’s reference value
of 100 µg/L. This patient worked in the purification process with occupational exposure to
MBOCA for 14 years. According to the environmental and biologic monitoring data and latency
period, and excluding other potential bladder carcinogen exposure, this worker was diagnosed as
having occupational bladder cancer due to high exposure to MBOCA through inhalation or dermal
absorption in the puriﬁcation area. This case ﬁnding supports that MBOCA is a potential human
carcinogen. Safe use of skin-protective equipment and respirators is required to prevent workers
from MBOCA exposure. Key words: bladder cancer, MBOCA, transitional cell carcinoma. Environ
Health Perspect 113:771–774 (2005). doi:10.1289/ehp.7666 available via http://dx.doi.org/ [Online
25 February 2005]
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urine screening test (Ward et al. 1990).
Workers were exposed to MBOCA for a
median employment period of 3.2 months
(between 1968 and 1981). Cystoscopy revealed
a papillary cell tumor in one worker, and low-
grade papillary transitional cell tumors of the
urinary bladder were diagnosed in 2 of the
remaining 200 workers examined by cystoscopy
(Ward et al. 1990). The U.S. Department of
Health and Human Services has determined
that MBOCA may reasonably be anticipated to
be a carcinogen (ATSDR 1994). IARC has
determined that MBOCA is probably carcino-
genic to humans (category 2A; IARC 1993).
The U.S. Environmental Protection Agency has
determined that MBOCA is a probable human
carcinogen (category 2A; ATSDR 1994). In the
Report on Carcinogens, Eleventh Edition
[National Toxicology Program (NTP) 2005],
the NTP reported that MBOCA may reason-
ably be anticipated to be a human carcinogen.
In this article we report a sentinel case of transi-
tional cell carcinoma of the urinary bladder
diagnosed in an MBOCA-manufacturing fac-
tory in Taiwan.
Case Presentation
Case report. A 52-year-old male chemical
worker was admitted to the hospital with a his-
tory of paroxysmal microscopic hematuria for
about 2 years and nocturia with gross hema-
turia about ﬁve times per night for 2 months.
He was a nonsmoker and denied taking any
medication. He did not use hair dye or reside
in an area with endemic blackfoot disease
(arsenic intoxication). Social alcohol drinking
was noted.
Microscopic hematuria was noted in the
periodic health examinations for about
2 years, but the patient ignored it. Two
months before admission, he developed noc-
turia about five times per night. Paroxysmal
painless hematuria was also noted. Gross
hematuria accompanied by lower abdominal
distress occurred 2 weeks before admission.
His body weight had decreased from 75 kg to
72 kg over the previous 3 months. He visited
the hospital, and an intravenous urogram
(IVU) showed a mass occupying half of the
bladder capacity. Cystoscopy revealed a mass
over the left dome area of the bladder.
Cystoscopic biopsy specimens revealed a grade
3/3 invasive transitional cell carcinoma with
marked necrosis. Radical cystectomy with ileal
conduit combined with radiotherapy was per-
formed because the bladder tissue showed
lymphovascular permeation with lymph node
metastasis. The worker is still on medical leave
because of disease.
Occupational history. The manufacturing
of MBOCA includes the reaction, neutraliza-
tion, washing, purification, and packing
processes. Briefly, o-chloroaniline is reacted
with sulfuric acid and formaldehyde under
the catalyst of stannous chloride for 3–4 hr.
The MBOCA products are then neutralized
with an alkali, sodium hydroxide, at a high
temperature. After washing and puriﬁcation,
the solid MBOCA is cut into pellets.
Although most of the processes are done in
closed systems and are automatic, leakage of
products from pipes and tanks has been
reported. The work schedule in the factory
where our patient worked has three 8-hr
shifts, and three or four workers in each shift
are assigned to each manufacturing line.
The patient was a farmer until he began
working at this factory. He worked in the
purification area of this MBOCA-producing
company for 14 years (1987–2001), and he
did not wear any personal protective equip-
ment during work. He denied working for
any chemical company other than his present
company. He occasionally applied pesticides
during agricultural work.
Environmental monitoring data. An area
sampling program to monitor MBOCA levels
in the work environment of this MBOCA
manufacturing factory was initiated by the
Taiwan Institute of Occupational Safety and
Health (IOSH), Council of Labor Affairs
(IOSH 2003a). The U.S. Occupational Safety
and Health Administration’s (OSHA) Analytic
Method 24 was adopted in this study (OSHA
1981). Briefly, an impinger filled with
0.1N HCl was used for sampling. The sam-
pling rate was 1 L/min. The sampling time was
> 6 hr or > 100 L air. The solution was then
analyzed with high-performance liquid chro-
matography (HPLC) with a 254 nm ultra-
violet (UV) detector. The detection limit was
0.056 µg/mL. A quality assurance and quality
control program was implemented during the
sampling and analysis procedures. All quality
tests were shown to be adequate (IOSH
2003a).
Two consecutive days’ air samples were col-
lected in the MBOCA-manufacturing factory,
in the areas where the reaction, neutralization,
washing, purification, and cutting/packing
processes took place. The concentration of
MBOCA was highest in the puriﬁcation area
(0.23–0.41 mg/m3, n = 2), followed by the
washing area (< 0.02–0.08 mg/m3, n = 7) and
the neutralization area (< 0.05–0.06 mg/m3,
n = 2) (IOSH 2003a). The concentrations of
MBOCA were within OSHA permissible
exposure level (0.22 mg/m3) except for the
purification area, where levels exceeded per-
missible levels.
Biological monitoring data. In addition to
environmental monitoring, the Taiwan IOSH
also collected workers’ urine to monitor
MBOCA concentrations. The U.S. National
Institute for Occupational Safety and Health
(NIOSH) analytic method 8302 (NIOSH
1994) and the method used by Robert et al.
(1999) were adopted in this study. Brieﬂy, sul-
famic acid (10 g/L) was used as urine preserva-
tive, and urine was neutralized by sodium
hydroxide (0.05 g/mL). After cleaning with
the Extrelut NT3 column (Merck, Darmstadt,
Germany) and evaporating with methanol, the
concentrated urine was analyzed by HPLC
with a 254 nm UV detector. The limit of
detection was 9.54 µg/L.
Urine from 10 workers in this MBOCA-
manufacturing company was analyzed. The
total urine MBOCA concentrations ranged
from 267.9 to 15701.1 µg/g creatinine, with a
mean of 5,544 µg/g creatinine (IOSH 2003b).
All the urine MBOCA concentrations far
exceeded the California Occupational Safety
and Health Administration (Cal-OSHA) refer-
ence value of 100 µg/L (Robert et al. 1999).
Discussion
Although the production of MBOCA in the
United States ceased in 1982, MBOCA is still
manufactured in other countries. It is also
widely used, primarily in industries producing
castable polyurethane elastomers (ATSDR
1994). Therefore, the health impact of
MBOCA is still of concern in occupational set-
tings in many countries. In this article we
report the ﬁrst known case of MBOCA-related
occupational bladder cancer in Taiwan, which
led to the establishment of recommended
exposure levels of MBOCA in the workplace.
This case report supports the conclusion that
MBOCA is a potential human carcinogen.
Environmental monitoring of MBOCA
levels in ambient air performed in the present
study showed that the concentration was high
in the purification process area (0.23–0.41
mg/m3) and exceeded the OSHA permissible
exposure level (0.22 mg/m3) and NIOSH’s
recommended exposure level of MBOCA
(3 mg/m3 as a 10-hr time-weighted average)
(Ward et al. 1990). The production quantity
of MBOCA at this patient’s plant was about
1,500 tons/year, which was much higher than
the 184–580 tons/year reported by Ward et al.
(1990). The air levels of MBOCA in this
plant were also higher than those in a poly-
urethane elastomer factory using MBOCA as
a curing agent (Clapp et al. 1991). No air-
borne MBOCA was detected in another poly-
urethane elastomer factory (Clapp et al. 1991).
In another study, personal sampling of the
breathing zone of workers for 6–7 hr every
other day found levels ranging from 0.002 to
0.0089 mg/m3 (Ichikawa et al. 1990).
In addition to exposure to high air concen-
trations of MBOCA, workers in the patient’s
plant also showed high levels of MBOCA in
urine. The urine MBOCA concentrations
ranged from 267.9 to 15701.1 µg/g creatinine
with a mean of 5,544 µg/g creatinine. The
urine MBOCA concentrations of all 10 work-
ers far exceeded the Cal-OSHA reference
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samples obtained by Ward et al. (1990) from
plant workers several months after production
ceased also showed detectable MBOCA levels
that ranged as high as 50,000 µg/L. Osorio
et al. (1990) reported a urine MBOCA level
of 1,700 µg/L 4 hr postexposure in a worker
who was accidentally sprayed with molten
MBOCA, but no acute symptoms or other
laboratory abnormalities were observed. The
urine MBOCA levels in the MBOCA-manu-
facturing factory workers were much higher
than in workers at a polyurethane elastomer
factory using MBOCA as a curing agent.
Clapp et al. (1991) reported concentrations
for mixers in the polyurethane elastomer fac-
tory ranging from 5 µg/L to > 100 µg/L urine
(average of 61.9 µg/L), whereas concentra-
tions for molders were considerably lower
(nondetectable to 50 µg/L urine; average of
14.8 µg/L). Workers in a plant that used
MBOCA had urine concentrations of
MBOCA ranging from 13 to 458 µg/L (mean
145 µg/L; Keeslar 1986). Another study of
150 workers with industrial exposure to
MBOCA in 19 factories showed that, at the
end of the work shift, excretion levels of
MBOCA ranged from < 0.5 µg/L to 1,600
µg/L, with the highest average urine concentra-
tions (600 µg/L) in workers directly involved
in MBOCA manufacture or use (Ducos et al.
1985). In a NIOSH study of urine samples
from mixers and molders in a polyurethane
elastomer factory (NIOSH 1986), the average
urine MBOCA level during the week was
approximately 30 µg/L for a mixer over a 5-day
work week; the level dropped to 8.9 µg/L over
the weekend. However, in Australia, monitor-
ing of workers at seven facilities that used
MBOCA in the manufacture of polyurethane
polymers showed that the average MBOCA
levels in the urine of the workers dropped from
29,600 to 10,400 µg/L within 8–9 months
after the implementation of an exposure pre-
vention program (Wan et al. 1989).
The bladder cancer patient reported here
worked in the puriﬁcation process with high
exposure to MBOCA for 14 years. He did
not wear any personal protective equipment
during work. Workers may inhale small parti-
cles of MBOCA in the air or absorb the agent
through the skin if they come into contact
with MBOCA dust or vapor (Chin et al.
1983; Cocker et al. 1988, 1990; Ichikawa
et al. 1990; NIOSH 1986). According to the
environmental monitoring data for the
patient’s factory, he may have been exposed
to high concentrations of MBOCA through
inhalation or dermal absorption.
Limited epidemiologic studies have
examined the incidence of cancer in workers
exposed to MBOCA, and three cases of
bladder cancer have been reported to be asso-
ciated with MBOCA exposure. Ward et al.
(1990) screened 385 MBOCA-exposed work-
ers and revealed a papillary tumor in one
worker after cystoscopy; two low-grade papil-
lary transitional cell carcinomas of the urinary
bladder were diagnosed in two of the remain-
ing 200 workers examined by cystoscopy.
Two of the men with bladder cancer in Ward
et al.’s study (Ward et al. 1988) were younger
than 30 years of age. The interval between the
time of first exposure and the initiation in
that study averaged 11.5 years. The latency
period in our case was 14 years, which was
compatible with that reported by Ward et al.
(1988). The present study adds evidence to
the potential carcinogenicity of MBOCA.
Human epidemiologic ﬁndings are supported
by results obtained in dogs (Stula et al. 1978).
Results in other animal species also support
the conclusion that MBOCA is a potential
carcinogen (ATSDR 1994). In addition to
the bladder, other target organs include the
lung, liver, breast, and Zymbal’s gland in rats
(Kommineni et al. 1979; Russfield et al.
1975; Stula et al. 1975) and the lung, liver,
and vascular system in mice (Russfield et al.
1975). No adequate epidemiologic studies of
MBOCA had been conducted. The present
case supports the conclusions from other
studies that MBOCA is potentially carcino-
genic to humans as well as animals, but it
does not substitute for the gap between epi-
demiologic evidence and animal studies.
Conclusion
This patient was a nonsmoker. Because no
other potential risk factors of bladder cancer
could be found, occupation-related cancer was
strongly suspected. This case ﬁnding supports
the conclusion that MBOCA is a potential
human carcinogen. In most cases, dermal
absorption is the most important occupational
exposure pathway. Workplace monitoring by
air sampling has been reported to be useless
because contamination may occur in the
absence of observable air levels (Clapp et al.
1991). Biological monitoring of urine
MBOCA concentration is a useful method to
assess percutaneous MBOCA absorption.
Because MBOCA is a potential human carcino-
gen, it is important to reduce exposure primar-
ily through engineering ventilation controls.
However, safe use of skin protective equipment
and respirators is required to prevent MBOCA
exposure. In addition, appropriate clearance of
spills, work training, air monitoring, and peri-
odic health examinations are recommended
(ATSDR 1994; Clapp et al. 1991).
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